InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,618.42
(
1.19%
)
Post# of 252434
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: genisi post# 128703

Tuesday, 10/18/2011 11:53:46 AM

Tuesday, October 18, 2011 11:53:46 AM

Post# of 252434

I'm sure those who can afford waiting few years, will wait. Not so sure they are the majority among diagnosed patients.




The majority of HCV patients which I referenced were the asymptomatic cases but I have no hard data to back up my assumption. The chronic patients, most of which are treatment-experienced patients having failed Peg/Riba alone, should most certainly be treated with currently available triple therapy.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up